usd6million

Basilea awarded additional CARB-X funding of USD6million to support the clinical development of antibiotic BAL2420

Funding is awarded following successful completion of IND-enabling studies and clinical study authorizationĀ USD 6 million in additional funding to support…

4 hours ago